(NU/1433-37) NewCo: The Provision of Business Consultancy to Assist Commercialisation of University Research.
Cancer and neurodegenerative diseases represent major unmet medical needs. It is estimated that approximately 20% of oncogenes are transcription factors (TFs) and many are critical for carcinogenesis. The global Cancer Drugs market was valued at US$92Bn in 2019 and is expected to reach US$124Bn by the end of 2026. The global neurodegenerative diseases drugs market size was valued at US$35.5Bn Million in 2018 and is projected to reach US$63Bn by the end of 2026. Specifically, we plan to target three cancer related T...
Buyer
NEWCASTLE UNIVERSITY
Value
£30,000
Published
30 Sept 2022
Closes
30 Sept 2022
Procurement details
Source
Find a Tender
Region
United Kingdom
Procurement method
Selective
Category
Services
Contract starts
Not provided
Contract ends
Not provided
CPV classifications
79400000
Business and management consultancy and related services
Lots
Lot 1 (NU/1433-37) NewCo: The Provision of Business Consultancy to Assist Commercialisation of University Research.
£30,000
Cancer and neurodegenerative diseases represent major unmet medical needs. It is estimated that approximately 20% of oncogenes are transcription factors (TFs) and many are critical for carcinogenesis. The global Cancer Drugs market was valued at US$92Bn in 2019 and is expected to reach US$124Bn by the end of 2026. The global neurodegenerative diseases drugs...
Delivery: North East (England)
Documents
No document metadata is available for this public record.
Contains public sector information licensed under the Open Government Licence v3.0.